R&D Center

Focusing on the field of anti-cancer drugs, with pharmaceutical R&D at its core.

The R&D center focuses on pharmaceutical R&D, with a particular emphasis on anti-cancer drugs. It undertakes functions including independent innovation, industry-academia-research collaboration, and the commercialization of research findings. Currently, the center has a research and development team of 61 members (accounting for 16.53% of the company’s total workforce), including 8 senior engineers and PhDs, whose expertise spans fields such as pharmacy and medicine. The center is equipped with 480 square meters of R&D space, a 600-square-meter pilot-scale facility, and equipment valued at 21.46 million yuan, enabling it to build a comprehensive platform covering the entire R&D process—from laboratory experiments to pilot-scale production. The center has established collaborative R&D networks with numerous universities and enterprises, including the Beijing Wentao Research Institute and Xinxiang Medical College, and has collectively secured over 40 national special projects (including 5 invention patents). Leveraging its provincial-level engineering technology research center, the center has helped the company obtain GMP certification and has been recognized with honors such as “Henan Province Specialized, Fine, and New Small and Medium-sized Enterprise.”

R&D Center
R&D Team

R&D Team

Our company has a team of experienced researchers.

Zhongjie Pharmaceutical places great importance on building its talent pool. The company boasts a team of experienced researchers with strong capabilities in developing new products. The technical leaders of our projects have many years of research and development experience in the industry and have either participated in or led provincial and municipal scientific research projects. Our R&D team comprises a total of 61 members, accounting for 16.53% of the company’s total workforce. Among them, 8 are senior engineers or PhD holders, and their expertise spans fields such as pharmaceuticals, medicine, chemical engineering, medicinal plants, and mechanical engineering, ensuring a diverse talent structure. The project’s technical leaders bring extensive industry R&D experience and have either participated in or led provincial and municipal scientific research projects. Over 90% of our management team hold degrees in pharmacy or related medical fields and have rich experience in R&D management.

61

R&D Team

8

Senior Engineer or Ph.D

R&D Achievements

Holds multiple technical certifications; the brand is trustworthy.

Currently, the company holds more than 40 valid intellectual property rights, including 5 invention patents and 1 new drug. The company is also developing 10 new products, such as dimethicone emulsion.

Silicon oil emulsion for the gastrointestinal tract, magnesium aluminum carbonate chewable tablets, glucosamine sulfate capsules, sitagliptin metformin extended-release tablets, and others.

With a range of advanced technologies, the company has participated in the formulation and revision of six relevant national and industry standards, thereby promoting the standardized development of the industry through the establishment of national standards.

A waste heat recovery heating system
Packaging box (Gliclazide tablets)
A pneumatic adsorption and fixing mechanism for capsule shells used in capsule filling machines.
An adjustable automatic feeding device for Chinese medicine slicing machines.
A multifunctional Chinese medicine slicing machine equipped with protective devices.
A strip slicer

New Products in Development

Driven by innovation, we connect and integrate scientific research findings with the clinical needs of patients.

Henan Zhongjie Pharmaceutical has always upheld the mission of “Caring for Life, Promoting Public Health,” driven by innovation and deeply integrating cutting-edge scientific research findings with the clinical needs of patients in a precise and targeted manner.

Relying on the R&D team’s continuous research and technological accumulation, the company currently has the following products under development:

Sitagliptin Metformin Extended-Release Tablets, Glucosamine Sulfate Capsules, Magnesium Aluminum Carbonate Chewable Tablets, Benidipine Hydrochloride Tablets, Sacubitril Valsartan Sodium TabletsStay tuned.
Each new product embodies the countless days and nights of hard work and dedication by Zhongjie’s R&D team, and carries with it the sincere original intention of bringing hope and health to patients.

R&D Collaboration

Working hand in hand with medical institutions to safeguard human health.

We are working hand in hand with medical universities, driven by our mission to safeguard human health and build an open and innovative ecosystem for medical research. We are deepening cooperation, breaking down barriers, and integrating resources.

Focusing on cutting-edge medical research and innovation in healthcare delivery models. Leveraging an integrated platform that brings together industry, academia, research, and application, we accelerate the clinical translation of scientific findings, ensuring that innovative breakthroughs benefit patients at large. Together...

Establish a talent-development system and cultivate versatile medical professionals to inject momentum into the industry’s development. Together, let’s tackle pressing health challenges, drive medical breakthroughs, and lay a solid foundation for human health and well-being.

Beijing Minkang Baicao Pharmaceutical Technology Co., Ltd.
Beijing Sunshine Noah Pharmaceutical Research Co., Ltd.
Beijing University of Chinese Medicine
Hangzhou Baicheng Pharmaceutical Technology Co., Ltd.
Henan University of Chinese Medicine
Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
Wentao Innovative Drug Research (Beijing) Co., Ltd.
Xinxiang Medical College